These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8230115)

  • 1. Inhibitors of blood platelet cAMP phosphodiesterase. 4. Structural variation of the side-chain terminus of water-soluble 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-one derivatives.
    Meanwell NA; Hewawasam P; Thomas JA; Wright JJ; Russell JW; Gamberdella M; Goldenberg HJ; Seiler SM; Zavoico GB
    J Med Chem; 1993 Oct; 36(22):3251-64. PubMed ID: 8230115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of blood platelet cAMP phosphodiesterase. 2. Structure-activity relationships associated with 1,3-dihydro-2H-imidazo[4,5-b]quinolin-2-ones substituted with functionalized side chains.
    Meanwell NA; Pearce BC; Roth HR; Smith EC; Wedding DL; Wright JJ; Buchanan JO; Baryla UM; Gamberdella M; Gillespie E
    J Med Chem; 1992 Jul; 35(14):2672-87. PubMed ID: 1321910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of blood platelet cAMP phosphodiesterase. 3. 1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-one derivatives with enhanced aqueous solubility.
    Meanwell NA; Dennis RD; Roth HR; Rosenfeld MJ; Smith EC; Wright JJ; Buchanan JO; Brassard CL; Gamberdella M; Gillespie E
    J Med Chem; 1992 Jul; 35(14):2688-96. PubMed ID: 1321911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,3-Dihydro-2H-imidazo[4,5-b]quinolin-2-ones--inhibitors of blood platelet cAMP phosphodiesterase and induced aggregation.
    Meanwell NA; Roth HR; Smith EC; Wedding DL; Wright JJ; Fleming JS; Gillespie E
    J Med Chem; 1991 Sep; 34(9):2906-16. PubMed ID: 1654430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase.
    Martinez GR; Walker KA; Hirschfeld DR; Bruno JJ; Yang DS; Maloney PJ
    J Med Chem; 1992 Feb; 35(4):620-8. PubMed ID: 1311763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imidazoquinoline derivatives: potent inhibitors of platelet cAMP phosphodiesterase which elevate cAMP levels and activate protein kinase in platelets.
    Seiler S; Gillespie E; Arnold AJ; Brassard CL; Meanwell NA; Fleming JS
    Thromb Res; 1991 Apr; 62(1-2):31-42. PubMed ID: 1649498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of a potent, new antithrombotic agent, 1,3-dihydro-7,8-dimethyl-2H-imidazo[4,5-b]quinolin-2-one (BMY-20844).
    Buchanan JO; Fleming JS; Cornish BT; Baryla UM; Gillespie E; Stanton HC; Seiler SM; Keely SL
    Thromb Res; 1989 Nov; 56(3):333-46. PubMed ID: 2559492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of cyclic AMP phosphodiesterase. 2. Structural variations of N-cyclohexyl-N-methyl-4-[(1,2,3,5-tetrahydro- 2-oxoimidazo[2,1-b]quinazolin-7-yl)-oxy]butyramide (RS-82856).
    Venuti MC; Jones GH; Alvarez R; Bruno JJ
    J Med Chem; 1987 Feb; 30(2):303-18. PubMed ID: 3027339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of cyclic AMP phosphodiesterase. 1. Analogues of cilostamide and anagrelide.
    Jones GH; Venuti MC; Alvarez R; Bruno JJ; Berks AH; Prince A
    J Med Chem; 1987 Feb; 30(2):295-303. PubMed ID: 3027338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo.
    Minami N; Suzuki Y; Yamamoto M; Kihira H; Imai E; Wada H; Kimura Y; Ikeda Y; Shiku H; Nishikawa M
    Life Sci; 1997; 61(25):PL 383-9. PubMed ID: 9416770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human platelet cyclic AMP phosphodiesterase and of platelet aggregation by a hemisynthetic flavonoid, amentoflavone hexaacetate.
    Beretz A; Briançon-Scheid F; Stierlé A; Corre G; Anton R; Cazenave JP
    Biochem Pharmacol; 1986 Jan; 35(2):257-62. PubMed ID: 3002388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of blood platelet cAMP phosphodiesterase: a QSAR analysis.
    Tiwari S; Sharma RC; Ojha TN; Singh P
    Drug Des Discov; 1995 Jan; 12(3):249-58. PubMed ID: 7662831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity.
    Sudo T; Tachibana K; Toga K; Tochizawa S; Inoue Y; Kimura Y; Hidaka H
    Biochem Pharmacol; 2000 Feb; 59(4):347-56. PubMed ID: 10644042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclic AMP phosphodiesterase activity of human blood platelet membrane by ADP.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1989 Aug; 984(1):113-8. PubMed ID: 2548620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-Bromo-1,5-dihydro-3,6-dimethylimidazo[2,1-b]quinazolin-2(3H)- one (Ro 15-2041), a potent antithrombotic agent that selectively inhibits platelet cyclic AMP-phosphodiesterase.
    Muggli R; Tschopp TB; Mittelholzer E; Baumgartner HR
    J Pharmacol Exp Ther; 1985 Oct; 235(1):212-9. PubMed ID: 2995647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
    Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
    J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
    [No Abstract]   [Full Text] [Related]  

  • 17. [Research and development of cilostazol: an antiplatelet agent].
    Nishi T; Kimura Y; Nakagawa K
    Yakugaku Zasshi; 2000 Dec; 120(12):1247-60. PubMed ID: 11193377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC; Guccione MA; Packham MA; Mustard JF
    Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
    Alvarez R; Banerjee GL; Bruno JJ; Jones GL; Littschwager K; Strosberg AM; Venuti MC
    Mol Pharmacol; 1986 Jun; 29(6):554-60. PubMed ID: 3012320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site.
    Roma G; Di Braccio M; Grossi G; Piras D; Leoncini G; Bruzzese D; Signorello MG; Fossa P; Mosti L
    J Med Chem; 2007 Jun; 50(12):2886-95. PubMed ID: 17500510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.